Podcasts

Psychiatrists push to normalize sexual health talks, address medication-related sexual side effects, and reduce stigma with holistic care and patient-safe communication.

Placebo and nocebo effects shape psychiatric care—how expectations and framing boost medication benefit and reduce side effects.

How to recognize racial trauma, sharpen diagnosis, and apply “Cost of Capable” and “weathering” to build trust and assess suicide risk.

Learn how clinicians tackle mood and substance use disorders together, boost patient engagement, and expand evidence-based addiction medications for bipolar and alcohol use.

A psychiatric clinician reveals how peers can spark small daily joy, beat burnout, and build balanced wellness that lasts.

AI is reshaping psychopharmacology—from TRD prediction to digital phenotyping—while exposing data limits, workflow hurdles, and safety risks in suicide tools.

Experts explain why every diagnosis needs metabolic screening, how to discuss risk safely, and when to use tools like PsyMetRiC to assess risk.

Psychiatrists unpack parental leave anxiety, FMLA gaps, and how smarter time-off planning can reduce postpartum depression and support working families.

ASCP panel offers deprescribing guidance to curb psychiatric overprescribing, simplify polypharmacy, and improve outcomes with tapering and

In the first ever episode of "On Your Mind With Erin Crown," explore how tribalism hurts the field of psychiatry and ultimately patient outcomes.

David Dunner, MD, FACPsych, reveals insights into rapid cycling roots, bipolar II, and weighing lithium as an often overlooked treatment option.

Experts reveal why psych medication nonadherence is common, how to discuss it without blame, and tools like CAE and injectables to prevent relapse.

Experts unpack why most psychiatric care relies on off‑label meds, how neuroscience guides safe polypharmacy, and what could reshape FDA approvals.

In this inaugural episode, experts discuss the limitations of current diagnosis-based frameworks in suicide research, emphasizing the need for more targeted interventions.

Experts urge early bipolar disorder treatment, highlighting lithium’s underuse despite neuroprotective, antisuicidal benefits and evidence that delays worsen outcomes and responsiveness.

Experts explain how careful pediatric psychopharmacology and early intervention protect development, curb relapse, and address substance-use risk.

Explore psychopharmacologic options for personality disorders in this podcast.

Psychiatry leaders unpack pharmacogenetic testing hype, spotlight 4 actionable genes, and urge evidence-based use with therapeutic drug monitoring for personalized treatment.

Psilocybin therapy shows fast, lasting relief for depression; clinicians discuss trial hurdles and emerging promise for PTSD and addiction in this podcast.

Learn when CBT/IPT beats medications, when to combine antidepressants, and why patient preference drives depression recovery in 6–12 weeks in this podcast.

A psychiatrist and psychiatric nurse practitioner discuss collaboration and patient support.

Explore GLP-1 agonists and their "truly transformative" role in psychiatry in this podcast.

Learn more about the treatment of depression, selective serotonin reuptake inhibitors, and pregnancy in this podcast.

Dissect psychodermatology with experts in both fields, from the American Academy of Dermatology 2026.

Explore how depression, anxiety, diet, and social factors shape heart disease—and why cardiology and psychiatry must team up for better care.

Experts unpack bereavement’s hidden health and economic toll.

Explore how Shambrekia Wise's "Sightseeing with Sandy" series promotes cultural humility and empathy in children through global travel and shared experiences.

Explore the transformative power of vulnerability in mental health and human connection with insights from Manizeh Mirza-Gruber, MD, and Frank Clark, MD.

In this podcast, Psychiatric Times editor-in-chief Dr. John J. Miller interviews Dr. Stephen Faraone, distinguished professor and vice chair of research of psychiatry and behavioral sciences at Upstate Medical University in Syracuse, New York, about the evolving world of nonpharmacologic interventions for ADHD, in particular digital therapeutics.

Research is underway to make psychedelics agents a treatment option for psychiatric disorders.